PTGER3 and Alzheimer disease: In the central nervous system (CNS), EP3 inhibition abrogated the migration and proliferation of human glioblastoma cells [18], alleviated cognitive deficits in the APP/PS1 mouse model of AD [19], attenuated brain injury, and improved neurological functional recovery in ischemic stroke model of mice [20].